HSDT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
HSDT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Helius Medical Technologies has the GF Score of 51, which implies that the company might have Poor future performance potential.
The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.
GF Score takes following five key aspects into consideration:
1. Financial Strength : 5/10Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.
Based on research and backtesting result, GuruFocus believes Helius Medical Technologies might have Poor future performance potential.
Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.
For the Medical Devices subindustry, Helius Medical Technologies's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Helius Medical Technologies's GF Score distribution charts can be found below:
* The bar in red indicates where Helius Medical Technologies's GF Score falls into.
Helius Medical Technologies (NAS:HSDT) GF Score Explanation
Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:
GF Score | Performance Potential and All-in-One Screener Examples (1) |
91 - 100 | Highest outperformance potential |
81 - 90 | Good outperformance potential |
71 - 80 | Likely to have average performance |
51 - 70 | Poor future performance potential |
0 - 50 | Worst future performance potential, or not enough data |
(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.
Thank you for viewing the detailed overview of Helius Medical Technologies's GF Score provided by GuruFocus.com. Please click on the following links to see related term pages.
Dane Andreeff | director, 10 percent owner, officer: President and CEO | C/O ANDREEFF EQUITY ADVISORS L.L.C., 140 E. ST. LUCIA LANE, SANTA ROSA BEACH FL 32459 |
Jeffrey S Mathiesen | director, officer: CFO and Treasurer | 43334 SEVEN MILE RD., SUITE 1000, NORTHVILLE MI 48167 |
Favit-van Pelt Antonella R. | officer: Chief Medical Officer | C/O HELIUS MEDICAL TECHNOLOGIES, INC., 642 NEWTOWN YARDLEY ROAD, NEWTOWN PA 18940 |
Paul Buckman | director | 12988 VALLEY VIEW RD, EDEN PRAIRIE MN 55402 |
Sherrie L Perkins | director | 5033 TANGLE LANE, HOUSTON TX 77056 |
Jennifer Laux | officer: Chief Commercial Officer | 642 NEWTOWN YARDLEY ROAD, SUITE 100, NEWTOWN PA 18940 |
Thomas E Griffin | director | C/O ENTELLUS MEDICAL, INC., 3600 HOLLY LANE NORTH, SUITE 40, PLYMOUTH MN 55447 |
Blane Walter | director | 500 OLDE WORTHINGTON ROAD, WESTERVILLE OH 43082 |
Edward M Straw | director | C/O ESTEE LAUDER COMPANIES, 767 FIFTH AVENUE, NEW YORK NY 10153 |
Joyce N Laviscount | officer: See Remarks | 100 ENDO BOULEVARD, CHADDS FORD PA 19317 |
Huaizheng Peng | director | HELIUS MEDICAL TECHNOLOGIES, INC., SUITE 400, 41 UNIVERSITY DRIVE, NEWTOWN PA 18940 |
Philippe Deschamps | director, 10 percent owner, officer: President & CEO | 105 BRADFORD RD, SUITE 420, WEXFORD PA 15090 |
Mitch E Tyler | director | HELIUS MEDICAL TECHNOLOGIES, INC., SUITE 400, 41 UNIVERSITY DRIVE, NEWTOWN PA 18940 |
Jonathan Sackier | 10 percent owner, officer: Chief Medical Officer | HELIUS MEDICAL TECHNOLOGIES, INC., SUITE 400, 41 UNIVERSITY DRIVE, NEWTOWN PA 18940 |
A&b (hk) Co Ltd | 10 percent owner | 8/F BLDG A TONGFANG INFORMATION HARBOR, NO 11 LANGSHAN ROAD NANSHAN DISTRICT, SHENZHEN F4 518057 |
From GuruFocus
By sperokesalga sperokesalga • 03-23-2023
By Marketwired • 10-12-2023
By Stock market mentor Stock market mentor • 01-05-2023
By Marketwired • 10-02-2023
By Marketwired • 08-10-2023
By Marketwired • 11-06-2023
By Marketwired • 11-02-2023
By Stock market mentor Stock market mentor • 01-10-2023
By Marketwired • 09-20-2023
By sperokesalga sperokesalga • 06-20-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.